نتایج جستجو برای: allopurinol

تعداد نتایج: 2809  

2012
Damián Pérez-Mazliah María C. Albareda María G. Alvarez Bruno Lococo Graciela L. Bertocchi Marcos Petti Rodolfo J. Viotti Susana A. Laucella

Allopurinol is the most popular commercially available xanthine oxidase inhibitor and it is widely used for treatment of symptomatic hyperuricaemia, or gout. Although, several anti-inflammatory actions of allopurinol have been demonstrated in vivo and in vitro, there have been few studies on the action of allopurinol on T cells. In the current study, we have assessed the effect of allopurinol o...

2005
A D Gavin A D Struthers

Objective: To study whether the effect of allopurinol on improvement of endothelial dysfunction in chronic heart failure (CHF) translates into improved exercise capacity and to examine whether allopurinol also improves B-type natriuretic peptide (BNP), the other important prognostic marker of CHF. Design: Randomised, double blind, placebo controlled crossover trial. Setting: Teaching hospital. ...

Journal: :Heart 2005
A D Gavin A D Struthers

OBJECTIVE To study whether the effect of allopurinol on improvement of endothelial dysfunction in chronic heart failure (CHF) translates into improved exercise capacity and to examine whether allopurinol also improves B-type natriuretic peptide (BNP), the other important prognostic marker of CHF. DESIGN Randomised, double blind, placebo controlled crossover trial. SETTING Teaching hospital....

2010
Michael A Becker H Ralph Schumacher Luis R Espinoza Alvin F Wells Patricia MacDonald Eric Lloyd Christopher Lademacher

INTRODUCTION The purpose of this study was to compare urate-lowering (UL) efficacy and safety of daily febuxostat and allopurinol in subjects with gout and serum urate (sUA) > or = 8.0 mg/dL in a six-month trial. METHODS Subjects (n = 2,269) were randomized to febuxostat 40 mg or 80 mg, or allopurinol 300 mg (200 mg in moderate renal impairment). Endpoints included the proportion of all subje...

2017
Brigitte Moreau Pierre Clement Yves Theoret Ernest G. Seidman

Background Thiopurines, azathioprine (AZA) and 6-mercaptopurine (6-MP) are common maintenance medications for inflammatory bowel disease (IBD). Excessive methylation via thiopurine methyltransferase (TPMT) frequently causes therapeutic failure. Allopurinol reduces excessive 6-methyl-mercaptopurine (6-MMP) while enhancing 6-thioguanine (6-TGN) levels. The aim of this study was to evaluate clinic...

Journal: :Circulation 2001
T Ukai C P Cheng H Tachibana A Igawa Z S Zhang H J Cheng W C Little

BACKGROUND Superoxide (O(2)(-)) generated by enhanced xanthine oxidase (XO) activity may contribute to the increased myocardial oxidative stress in heart failure (CHF). Because blocking XO with allopurinol augments myofilament Ca(2+) sensitivity in reperfusion injury and CHF, we hypothesized that it may improve adrenergic inotropic responsiveness in CHF. METHODS AND RESULTS We studied the eff...

2001
Donald J. Nelson Christopher J. L. Bugge Gertrude B. Elion

Leishmania donovani and Leishmania braziliensis grown in culture formed millimolar concentrations of allopurinol ribonucleoside 5’-monophosphate from [6“C]allopurinol. In addition, allopurinol l-ribonucleoside, oxipurinol riboside 5’-monophosphate, and three new metabolites of allopurinol, namely, 4-aminopyrazolo(3,4-d)pyrimidine ribonucleoside V-monophosphate and the corresponding diand tripho...

2014
Adile Berna Dursun Osman Z Sahin

BACKGROUND Allopurinol is an effective urate-lowering drug that is well tolerated by the majority of patients. Patients with chronic renal insufficiency have an increased risk of hypersensitivity reactions with allopurinol. CASE PRESENTATION 75 year old male patient with gout, renal insufficiency, history of metastatic colorectal carcinoma status post-resection was referred to Allergy clinic ...

Journal: :Singapore medical journal 2008
H Y Lee J T Ariyasinghe T Thirumoorthy

INTRODUCTION Allopurinol is a widely-prescribed urate-lowering agent. Allopurinol hypersensitivity syndrome, a severe form of cutaneous adverse reaction, is associated with significant mortality and morbidity. The aim of this study was to document the clinical presentation of allopurinol hypersensitivity in a local population, examine the indications for urate-lowering therapy and to identify p...

Journal: :Bone 2016
Ujani Basu James Goodbrand Marion E T McMurdo Peter T Donnan Mark McGilchrist Helen Frost Jacob George Miles D Witham

BACKGROUND Allopurinol reduces oxidative stress and interacts with purinergic signalling systems important in bone metabolism and muscle function. We assessed whether allopurinol use was associated with a reduced incidence of hip fracture in older people. METHODS Analysis of prospective, routinely-collected health and social care data on patients undergoing health and social work assessment i...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید